Faithward Advisors, LLC

13F Portfolio Filings

Latest 13F report
Q2 2024 - Aug 14, 2024
Value $
$553M
Signature - Title
Adrian Evan Young - Managing Member/Chief Compliance Officer
Location
275 Hess Blvd, Lancaster, PA
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Date Filed
Q2 2024 252 $553M +$73.2M -$57.3M +$15.9M IBD, GLRY, WWJD, AGZ, BITO 13F-HR 8/14/2024, 02:59 PM
Q1 2024 251 $551M +$82M -$21.1M +$60.9M IBD, IBTE, GLRY, BITO, WWJD 13F-HR 5/15/2024, 02:40 PM
Q4 2023 255 $440M +$41.8M -$44M -$2.23M IBD, IBTE, GLRY, WWJD, BITO 13F-HR 2/14/2024, 05:31 PM
Q3 2023 247 $394M +$35.3M -$44.5M -$9.17M IBD, GLRY, WWJD, IBTE, SCHQ 13F-HR 11/14/2023, 07:58 PM
Q2 2023 268 $433M +$25.6M -$49.9M -$24.2M SCHQ, GLRY, IBD, WWJD, BITO 13F-HR 8/14/2023, 06:36 PM
Q1 2023 308 $432M +$78.7M -$123M -$44.5M IBD, GLRY, SCHQ, WWJD, IVOL 13F-HR 5/15/2023, 05:08 PM
Q4 2022 266 $460M +$134M -$115M +$18.9M GLRY, IBD, SCHQ, WWJD, TPLC 13F-HR 2/14/2023, 02:26 PM
Q3 2022 236 $422M +$121M -$119M +$1.92M IBD, TPLC, WWJD, VGSH, IVOL Restatement 11/18/2022, 09:25 AM
Q2 2022 254 $446M +$42.3M -$33.5M +$8.84M IBD, FEVR, BIBL, GLRY, IEF 13F-HR 8/12/2022, 01:13 PM
Q1 2022 268 $514M +$33.8M -$14.6M +$19.2M IBD, FEVR, IVOL, BIBL, GLRY 13F-HR 5/16/2022, 12:30 PM
Q4 2021 265 $524M +$106M -$100M +$5.98M IBD, FEVR, BIBL, IVOL, GLRY 13F-HR 2/14/2022, 05:21 PM
Q3 2021 277 $514M +$37.7M -$22.4M +$15.4M IBD, FEVR, IVOL, GLRY, PDBC 13F-HR 11/15/2021, 05:44 PM
Q2 2021 264 $505M +$145M -$121M +$23.8M IBD, FEVR, IVOL, GLRY, PDBC 13F-HR 8/13/2021, 05:37 PM
Q1 2021 238 $447M +$254M -$39.5M +$214M IBD, IEI, GLRY, IEF, FEVR 13F-HR 5/13/2021, 04:17 PM
Q4 2020 119 $229M +$56.2M -$257M -$201M IBD, GLRY, FEVR, WWJD, VMBS 13F-HR 2/16/2021, 06:04 PM
Q3 2020 212 $413M +$113M -$103M +$10.7M IEI, IBD, IEF, WWJD, TPLC 13F-HR 11/13/2020, 09:37 AM
Q2 2020 206 $385M +$113M -$126M -$12.6M IEF, TPLC, WWJD, VMBS, SHY 13F-HR 8/13/2020, 10:49 AM
Q1 2020 236 $355M +$100M -$101M -$1.21M IEF, TPLC, ISMD, VMBS, JPMF 13F-HR 5/11/2020, 09:20 PM
Q4 2019 240 $425M +$199M -$248M -$48.8M TPLC, ISMD, IEF, TIP, RINF 13F-HR 1/22/2020, 04:40 PM
Q3 2019 101 $452M $0 $0 RINF, ISMD, BLES, IBD, LEMB 13F-HR 11/14/2019, 07:02 PM